Golightly / Teitelbaum / Simendinger Renal Pharmacotherapy
2. Auflage 2021
ISBN: 978-3-030-58649-2
Verlag: Springer, Berlin
Seite exportieren
Buch, Englisch,
824 Seiten, Kartoniert, Book, Format (B × H): 210 mm x 279 mm
- Renal Pharmacotherapy, 2013, 978-1-4614-5799-2
Dosage Adjustment of Medications Eliminated by the Kidneys
2. Auflage 2021,
824 Seiten, Kartoniert, Book, Format (B × H): 210 mm x 279 mm
ISBN: 978-3-030-58649-2
Verlag: Springer, Berlin
Seite exportieren
- versandkostenfreie Lieferung
- Lieferfrist: bis zu 10 Tage
This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types.
Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function.
Stolpman, Nancy M.
Larry K. Golightly, PharmDClinical Research PharmacistUniversity of Colorado HospitalAurora, CO 80045larry.golightly@uchealth.org Isaac Teitelbaum, MD, FACPProfessor of MedicineRenal Medicine and Hypertension Section, Division of General Internal MedicineUniversity of Colorado School of Medicine andDirector, Home Dialysis ProgramUniversity of Colorado HospitalAurora, CO 80045isaac.teitelbaum@cuanschutz.edu Bonita A. Simendinger, PharmD, BCPSP&T Formulary Compliance SpecialistUniversity of Colorado HospitalAurora, CO 80045bonita.simendinger@uchealth.org Tyree H. Kiser, PharmD, BCPS, FCCP, FCCMProfessor, Department of Clinical PharmacyUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences andCritical Care Pharmacy SpecialistUniversity of Colorado HospitalAurora, CO 80045ty.kiser@cuanschutz.edu Gerard R. Barber, RPh, MPH, FASHPClinical Assistant Professor, Department of Clinical PharmacyUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical SciencesAurora, CO 80045gerard.barber@cuanschutz.edu Nancy M. Stolpman, PharmD, PhDAssociate Clinical ProfessorUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences andLead Director of PharmacyUCHealthAurora, CO 80045nancy.stolpman@uchealth.org
A: Acamprosate to AztreonamB: Bacitracin to ButorphanolC: Capecitabine to CycloserineD: Dabigatran to DyphyllineE: Edetate Calcium Disodium to ExenatideF: Famciclovir to FosfomycinG: Gabapentin to GlyburideH: Hetastarch to HydroxyureaI: Ibandronate to ItraconazoleK: Kanamycin to KetorolacL: Lacosamide to LurasidoneM: Magnesium Citrate to Mycophenolate MofetilN: Nabumetone to NorfloxacinO: Ofloxacin to OxcarbazepineP: Paliperidone to PyridostigmineQ: Quinapril to QuinineR: Ramipril to RuxolitinibS: Salsalate to SunitinibT: Tadalafil to TrospiumV: Valacyclovir to VoriconazoleZ: Zalcitabine to ZonisamideProprietary Name Index
Professional/practitioner
This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types.
Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function.
Stolpman, Nancy M.
Larry K. Golightly, PharmDClinical Research PharmacistUniversity of Colorado HospitalAurora, CO 80045larry.golightly@uchealth.org Isaac Teitelbaum, MD, FACPProfessor of MedicineRenal Medicine and Hypertension Section, Division of General Internal MedicineUniversity of Colorado School of Medicine andDirector, Home Dialysis ProgramUniversity of Colorado HospitalAurora, CO 80045isaac.teitelbaum@cuanschutz.edu Bonita A. Simendinger, PharmD, BCPSP&T Formulary Compliance SpecialistUniversity of Colorado HospitalAurora, CO 80045bonita.simendinger@uchealth.org Tyree H. Kiser, PharmD, BCPS, FCCP, FCCMProfessor, Department of Clinical PharmacyUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences andCritical Care Pharmacy SpecialistUniversity of Colorado HospitalAurora, CO 80045ty.kiser@cuanschutz.edu Gerard R. Barber, RPh, MPH, FASHPClinical Assistant Professor, Department of Clinical PharmacyUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical SciencesAurora, CO 80045gerard.barber@cuanschutz.edu Nancy M. Stolpman, PharmD, PhDAssociate Clinical ProfessorUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences andLead Director of PharmacyUCHealthAurora, CO 80045nancy.stolpman@uchealth.org
A: Acamprosate to AztreonamB: Bacitracin to ButorphanolC: Capecitabine to CycloserineD: Dabigatran to DyphyllineE: Edetate Calcium Disodium to ExenatideF: Famciclovir to FosfomycinG: Gabapentin to GlyburideH: Hetastarch to HydroxyureaI: Ibandronate to ItraconazoleK: Kanamycin to KetorolacL: Lacosamide to LurasidoneM: Magnesium Citrate to Mycophenolate MofetilN: Nabumetone to NorfloxacinO: Ofloxacin to OxcarbazepineP: Paliperidone to PyridostigmineQ: Quinapril to QuinineR: Ramipril to RuxolitinibS: Salsalate to SunitinibT: Tadalafil to TrospiumV: Valacyclovir to VoriconazoleZ: Zalcitabine to ZonisamideProprietary Name Index
Professional/practitioner
- versandkostenfreie Lieferung
74,89 € (inkl. MwSt.)
Webcode: sack.de/r6zwk